The DOI matches its Crossref record; 466 of the 466 references it cites were found in a registry or an index.
Antimicrobial Resistance in ESKAPE Pathogens
Open accessAbstract
Antimicrobial-resistant ESKAPE ( E nterococcus faecium , S taphylococcus aureus , K lebsiella pneumoniae , A cinetobacter baumannii , P seudomonas aeruginosa , and E nterobacter species) pathogens represent a global threat to human health. The acquisition of antimicrobial resistance genes by ESKAPE pathogens has reduced the treatment options for serious infections, increased the burden of disease, and increased death rates due to treatment failure and requires a coordinated global response for antimicrobial resistance surveillance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is currently included in the ESKAPE group (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species), a group of the most important bacteria involved in infections and characterized by multidrug resistance [1].”
From Molecular Mechanisms of Drug Resistance in Staphylococcus aureus (2022) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–466 of 466
Methicillin-Susceptible, Vancomycin-ResistantStaphylococcus aureus, Brazil
Panesso, D., Planet, P. J., Díaz, L., Hugonnet, J., Tran, T. T., Narechania, A., Munita, J. M., Rincón, S., Carvajal, L. P., Reyes, J., et al. (2015) · Emerging infectious diseases · doi:10.3201/eid2110.141914 · Cited by 61
Nwugo, C. C., Arivett, B. A., Zimbler, D. L., Gaddy, J. A., Richards, A. M., & Actis, L. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051936 · Cited by 61
What are the economic barriers of antibiotic R&D and how can we overcome them?
Renwick, M. J., & Mossialos, E. A. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1515908 · Cited by 61
Characterization of the tetracycline resistance gene of plasmid pT181 of Staphylococcus aureus
Mojumdar, M., & Khan, S. A. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.12.5522-5528.1988 · Cited by 60
Distribution of the antiseptic-resistance geneqacEΔ1in Gram-positive bacteria
Kazama, H., Hamashima, H., Sasatsu, M., & Arai, T. (1998) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1998.tb13160.x · Cited by 60
Boutoille, D., Corvec, S., Caroff, N., Giraudeau, C., Espaze, E., Caillon, J., Plésiat, P., & Reynaud, A. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00882-6 · Cited by 60
Bhandari, T., & Nizet, V. (2014) · Infectious Diseases and Therapy · doi:10.1007/s40121-014-0030-1 · Cited by 60
Renzoni, A., Barras, C., François, P., Charbonnier, Y., Huggler, E., Garzoni, C., Kelley, W. L., Majcherczyk, P. A., Schrenzel, J., Lew, D. P., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00113-06 · Cited by 58
Hamidian, M., & Hall, R. M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx206 · Cited by 57
Hoggarth, A., Weaver, A., Pu, Q., Huang, T. L., Schettler, J., Chen, F., Yuan, X., & Wu, M. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s189847 · Cited by 57
Innovative Medicines Initiative (IMI)
Takač, J.-M., & Milena (2008) · Farmaceutski glasnik : glasilo Hrvatskog farmaceutskog društva · Cited by 55
Gouliouris, T., Warne, B., Cartwright, E. J. P., Bedford, L., Weerasuriya, C. K., Raven, K. E., Brown, N. M., Török, M. E., Limmathurotsakul, D., & Peacock, S. J. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky075 · Cited by 55
Δρούγκα, Ε., Foka, A., Liakopoulos, A., Doudoulakakis, A., Jelastopulu, E., Chini, V., Spiliopoulou, A., Levidiotou, S., Panagea, T., Vogiatzi, A., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12624 · Cited by 54
Properties of IncP-2 plasmids of Pseudomonas spp
Jacoby, G. A., Sutton, L., Knobel, L., & Mammen, P. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.2.168 · Cited by 54
Snydman, D. R., McDermott, L. A., Jacobus, N. V., Kerstein, K. O., Grossman, T. H., & Sutcliffe, J. A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02206-17 · Cited by 54
Evolution of the IS CR3 Group of IS CR Elements
Toleman, M. A., & Walsh, T. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00479-08 · Cited by 53
Various pathways leading to the acquisition of antibiotic resistance by natural transformation
Domingues, S., Nielsen, K. M., & Silva, G. (2012) · Mobile Genetic Elements · doi:10.4161/mge.23089 · Cited by 53
Sécher, T., Fauconnier, L., Szade, A., Rutschi, O., Fas, S. C., Ryffel, B., & Rudolf, M. P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr038 · Cited by 53
Hall, J. M., Corea, E. M., Sanjeewani, H. D. A., & Inglis, T. J. J. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.076760-0 · Cited by 52
Characterization of the Conjugation System Associated with the Staphylococcus aureus Plasmid pJE1
EVANS, J., & Dyke, K. G. H. (1988) · Microbiology · doi:10.1099/00221287-134-1-1 · Cited by 52
Mašlaňová, I., Stříbná, S., Doškař, J., & Pantůček, R. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnw211 · Cited by 52
Tracking antibiotic resistance
Beatson, S. A., & Walker, M. J. (2014) · Science · doi:10.1126/science.1260471 · Cited by 51
Self-citationCox, G., Koteva, K. K., & Wright, G. D. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku057 · Cited by 51
Molecular Characterization of the Multidrug Resistant Escherichia coli ST131 Clone
Schembri, M. A., Zakour, N. L. B., Phan, M., Forde, B. M., Stanton-Cook, M. J., & Beatson, S. A. (2015) · Pathogens · doi:10.3390/pathogens4030422 · Cited by 48
Self-citationBoyle‐Vavra, S., Challapalli, M., & Daum, R. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.2036-2039.2003 · Cited by 48
Polyclonal Diffusion of Beta-Lactamase-Producing Enterococcus faecium
Sarti, M., Campanile, F., Sabia, C., Santagati, M., Gargiulo, R., & Stefani, S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05640-11 · Cited by 48
Biology of the staphylococcal conjugative multiresistance plasmid pSK41
Liu, M. A., Kwong, S. M., Jensen, S. O., Brzoska, A. J., & Firth, N. (2013) · Plasmid · doi:10.1016/j.plasmid.2013.02.001 · Cited by 47
Iguchi, S., Mizutani, T., Hiramatsu, K., & Kikuchi, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155512 · Cited by 47
Haniford, D. B., & Ellis, M. J. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0002-2014 · Cited by 46
Analytical Framework for Examining the Value of Antibacterial Products
Outterson, K., Sertkaya, A., Eyraud, J. T., Birkenback, A., Franz, C., Ackerley, N., & Overton, V. (2014) · bepress Legal Repository · Cited by 46
Synthetic Immunotherapeutics against Gram-negative Pathogens
Feigman, M. S., Kim, S., Pidgeon, S. E., Yu, Y., Ongwae, G. M., Patel, D. S., Regen, S. L., Im, W., & Pires, M. M. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.05.019 · Cited by 46
Chlebowicz, M. A., Mašlaňová, I., Kuntová, L., Grundmann, H., Pantůček, R., Doškař, J., van Dijl, J. M., & Buist, G. (2014) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.05.010 · Cited by 44
Analysis of the prototypical Staphylococcus aureus multiresistance plasmid pSK1
Jensen, S. O., Apisiridej, S., Kwong, S. M., Yang, J. Y. H., Skurray, R. A., & Firth, N. (2010) · Plasmid · doi:10.1016/j.plasmid.2010.06.001 · Cited by 43
Molecular Epidemiology of Methicillin-ResistantStaphylococcus aureus, Rural Southwestern Alaska1
David, M. Z., Rudolph, K. M., Hennessy, T. W., Boyle‐Vavra, S., & Daum, R. S. (2008) · Emerging infectious diseases · doi:10.3201/eid1411.080381 · Cited by 42
Ainsworth, S., Ketter, P. M., Yu, J., Grimm, R. C., May, H. C., Cap, A. P., Chambers, J. P., Guentzel, M. N., & Arulanandam, B. P. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.05.017 · Cited by 42
Lin, Y. C., Chen, T. L., Ju, H. L., Chen, H. S., Wang, F. D., Yu, K. W., & Liu, C. Y. (2006) · PubMed · Cited by 41
Årdal, C., Baraldi, E., Theuretzbacher, U., Outterson, K., Plahte, J., Ciabuschi, F., & Røttingen, J. (2018) · Journal of Pharmaceutical Policy and Practice · doi:10.1186/s40545-018-0135-0 · Cited by 41
Zscheck, K. K., & Murray, B. E. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1736 · Cited by 39
Richter, S. S., Doern, G. V., Heilmann, K. P., Miner, S. A., Tendolkar, S., Riahi, F., & Diekema, D. J. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.03109-15 · Cited by 39
New Drugs to Tackle Antimicrobial Resistance: Analysis of EU Policy OptionsPreprint
Sharma, P., & Towse, A. (2010) · SSRN Electronic Journal · doi:10.2139/ssrn.2640028 · Cited by 39
Zhou, K., Tang, X., Wang, L., Guo, Z., Xiao, S., Wang, Q., & Zhuo, C. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy691 · Cited by 39
Hamidian, M., & Hall, R. M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt488 · Cited by 38
Chowdhury, P. R., Scott, M. J., & Djordjevic, S. P. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw471 · Cited by 37
Aguilar-Rodea, P., Zúñiga, G., Rodríguez-Espino, B. A., Olivares-Cervantes, A. L., Gamiño-Arroyo, A. E., Moreno‐Espinosa, S., de la Rosa‐Zamboni, D., Martínez, B. L., Castellanos-Cruz, M. D. C., Parra‐Ortega, I., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172882 · Cited by 37
Botelho, J., Grosso, F., Quinteira, S., Mabrouk, A., & Peixe, L. M. S. V. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx143 · Cited by 37
Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection
Kufel, W. D., Devanathan, A. S., Marx, A. H., Weber, D. J., & Daniels, L. M. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1990 · Cited by 37
Omadacycline: A New Tetracycline Antibiotic
Dougherty, J. A., Sucher, A. J., Chahine, E. B., & Shihadeh, K. C. (2018) · Annals of Pharmacotherapy · doi:10.1177/1060028018818094 · Cited by 37
Kazama, H., Hamashima, H., Sasatsu, M., & Arai, T. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb13593.x · Cited by 33
Fan, X., Wu, Y., Xiao, M., Xu, Z.-P., Kudinha, T., Bazaj, A., Kong, F., & Xu, Y. (2016) · Scientific Reports · doi:10.1038/srep26522 · Cited by 33
Outbreak of vanB vancomycin-resistant Enterococcus faecium colonization in a neonatal service
Lister, D. M., Kotsanas, D., Ballard, S. A., Howden, B. P., Carse, E., Tan, K., Scott, C., Gillespie, E. E., Mahony, A. A., Doherty, R. R., et al. (2015) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.05.047 · Cited by 32
Tavares, L. C. B., de Vasconcellos, F. M., de Sousa, W. V., Rocchetti, T. T., Mondelli, A. L., Ferreira, A. M., Montelli, A. C., Sadatsune, T., Tiba‐Casas, M. R., & Camargo, C. H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02898 · Cited by 32
The role of new β-lactamase inhibitors in gram-negative infections
Vena, A., Castaldo, N., & Bassetti, M. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000600 · Cited by 32
Hu, L., Liu, Y., Deng, L., Zhong, Q., Hang, Y., Wang, Z., Zhan, L., Wang, L., & Yu, F. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01190 · Cited by 31
Gonçalves, A., Igrejas, G., Radhouani, H., López, M., Guerra, A., Petrucci‐Fonseca, F., Alcaide, E. M., Zorrilla, I., Serra, R., Torres, C., et al. (2011) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2011.09.074 · Cited by 30
Chen, Y., Qu, T., Yu, Y., Zhou, J., & Li, L. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46702-0 · Cited by 30
Herc, E. S., Kauffman, C. A., Marini, B. L., Perissinotti, A. J., & Miceli, M. H. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1312665 · Cited by 29
Roca, A., Quintó, L., Abacassamo, F., Morais, L., Vallès, X., Espasa, M., Sigaúque, B., Sacarlal, J., Macete, E., Nhacolo, A., et al. (2008) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2008.02061.x · Cited by 25
Creech, C. B., Frenck, R. W., Fiquet, A., Feldman, R., Kankam, M. K., Pathirana, S., Baber, J., Radley, D. R., Cooper, D., Eiden, J., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz532 · Cited by 20
New Drugs to Tackle Antimicrobial Resistance: Analysis of EU Policy Options
Sharma, P. R., & Towse, A. (2011) · Monographs · Cited by 19
What's in a Name? IS Swi1 Corresponds to Transposons Related to Tn 2 and Tn 3
Partridge, S. R. (2015) · mBio · doi:10.1128/mbio.01344-15 · Cited by 16
Mobilization of bla BKC-1 by IS Kpn23 ?
Partridge, S. R. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00785-16 · Cited by 14
Risk factors for vancomycin-resistant Enterococcus colonization in hematologic patients
Mioljević, V., Markovic‐Denic, L., Vidović, A., Jovanović, M., Tošić, T., & Tomin, D. (2013) · Vojnosanitetski pregled · doi:10.2298/vsp1312109m · Cited by 12
Perilli, M., Sabatini, A., Pontieri, E., Celenza, G., Segatore, B., Bottoni, C., Bellio, P., Mancini, A., Marcoccia, F., Brisdelli, F., et al. (2014) · Microbial Drug Resistance · doi:10.1089/mdr.2014.0056 · Cited by 12
Etiología de las infecciones quirúrgicas en pacientes sometidos a craneotomía
Múñez, E., Ramos, A., de Espejo, T. Á., Vaqué, J., Sánchez–Payá, J., Pastor, V., & Asensio, Á. (2012) · Neurocirugía · doi:10.1016/j.neucir.2011.08.002 · Cited by 8
Wiggins, A. G., LaVoie, S. P., Wireman, J., & Summers, A. O. (2018) · Plasmid · doi:10.1016/j.plasmid.2018.08.003 · Cited by 3
(2017) · PubMed Central
Cited by
Bacterial Antibiotic Resistance: The Most Critical Pathogens
Mancuso, G., Midiri, A., Gerace, E., & Biondo, C. (2021) · Pathogens · doi:10.3390/pathogens10101310 · Cited by 1,332
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
Miller, W. R., & Arias, C. A. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01054-w · Cited by 862
Identification of antimicrobial peptides from the human gut microbiome using deep learning
Ma, Y., Guo, Z., Xia, B., Zhang, Y., Liu, X., Yu, Y., Tang, N., Tong, X., Wang, M., Ye, X., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01226-0 · Cited by 490
A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides
Browne, K., Chakraborty, S., Chen, R., Willcox, M. D., Black, D. S., Walsh, W. R., & Kumar, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197047 · Cited by 482
Molecular Mechanisms of Drug Resistance in Staphylococcus aureus
Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., & Marusza, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158088 · Cited by 412
Metadata
- Authors
- De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2020-06-17
- Volume
- 33
- Issue
- 3
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W3024693033
- Cited by
- 2,078
- References
- 466
- FWCI
- 65.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.